Results 51 to 60 of about 41,056 (165)

Myocarditis and pericarditis in individuals exposed to the Ad26.COV2.S, BNT162b2 mRNA, or mRNA-1273 SARS-CoV-2 vaccines [PDF]

, 2023
IMPORTANCE: There is a high level of public and professional interest related to potential safety issues of the COVID-19 vaccines; however, no serious adverse cardiovascular events were reported in phase 3 randomized controlled trials of their safety and
Kragholm, Kristian Hay, Pareek, Manan, Polverino, Paolo, Sessa, Francesco, Sessa, Maurizio, Sessa, Pasquale   +5 more
core   +2 more sources

Longitudinal Dynamics of SARS-CoV-2 IgG Antibody Responses after the Two-Dose Regimen of BNT162b2 Vaccination and the Effect of a Third Dose on Healthcare Workers in Japan

Vaccines, 2022
Analysis of longitudinal dynamics of humoral immune responses to the BNT162b2 COVID-19 vaccine might provide useful information to predict the effectiveness of BNT162b2 in preventing SARS-CoV-2 infection.
Atsuhiko Sakamoto, Michinobu Yoshimura, Ryota Itoh, Ryo Ozuru, Kazunari Ishii, Yusuke Sechi, Shigeki Nabeshima, Kenji Hiromatsu   +7 more
doaj   +1 more source

High viral loads: what drives fatal cases of COVID-19 in vaccinees? an autopsy study: [Preprint] [PDF]

, 2021
Background: The rate of SARS-CoV-2 breakthrough infections in vaccinees is becoming an increasingly serious issue. Objective: To determine the causes of death, histological organ alteration, and viral spread in relation to demographic, clinical ...
Beer, Martin, Boesmueller, Hans, Boor, Peter, Braun, Georg, Claus, Rainer, Dintner, Sebastian, Esposito, Irene, Grosser, Bianca, Hilsenbeck, Julia, Hirschbuehl, Klaus, Kling, Elisabeth, Kroencke, Thomas, Maccagno, Andrea, Maerkl, Bruno, Neidig, Michael, Pablik, Jessica, Rentschler, Lukas, Schaller, Tina, Seidl, Maximilian, Sipos, Eva, Spring, Oliver, Wylezich, Claudia   +21 more
core   +1 more source

Humoral immunity against SARS-CoV-2 evoked by heterologous vaccination groups using the CoronaVac (Sinovac) and BNT162b2 (Pfizer/BioNTech) vaccines in Chile

Frontiers in Public Health, 2023
IntroductionSevere acute respiratory syndrome virus 2 (SARS-CoV-2) has caused over million deaths worldwide, with more than 61,000 deaths in Chile. The Chilean government has implemented a vaccination program against SARS-CoV-2, with over 17.7 million ...
Diego A. Díaz-Dinamarca, Pablo Díaz, Gisselle Barra, Rodrigo Puentes, Loredana Arata, Jonnathan Grossolli, Boris Riveros-Rodriguez, Luis Ardiles, Julio Santelises, Julio Santelises, Valeria Vasquez-Saez, Daniel F. Escobar, Daniel Soto, Cecilia Canales, Janepsy Díaz, Liliana Lamperti, Daniela Castillo, Mychel Urra, Felipe Zuñiga, Valeska Ormazabal, Estefanía Nova-Lamperti, Rosana Benítez, Alejandra Rivera, Claudia P. Cortes, Claudia P. Cortes, Claudia P. Cortes, María Teresa Valenzuela, Heriberto E. García-Escorza, Abel E. Vasquez, Abel E. Vasquez, Abel E. Vasquez   +30 more
doaj   +1 more source

Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK [PDF]

, 2021
The effectiveness of the BNT162b2 and ChAdOx1 vaccines against new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections requires continuous re-evaluation, given the increasingly dominant B.1.617.2 (Delta) variant.
Bell, J, Cook, D, Crook, D, Diamond, I, Eyre, DW, Farrar, J, Hay, J, House, T, Matthews, PC, Newton, JN, Peto, TEA, Pouwels, KB, Pritchard, E, Rourke, E, Stoesser, N, Studley, R, Vihta, K-D, Walker, AS   +17 more
core  

COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants [PDF]

, 2021
As SARS-CoV-2 has been circulating for over a year, dozens of vaccine candidates are under development or in clinical use. The BNT162b2 mRNA COVID-19 vaccine induces spike protein-specific neutralizing antibodies associated with protective immunity.
Hepojoki, Jussi, Huttunen, Moona, Häkkinen, Hanni K., Ivaska, Lauri, Jalkanen, Pinja, Julkunen, Ilkka, Kakkola, Laura, Kantele, Anu, Kolehmainen, Pekka, Kuivanen, Suvi, Lempainen, Johanna, Levonen, Iris, Lundberg, Rickard, Maljanen, Sari, Miller, Taru, Naves, Rauno, Nousiainen, Arttu, Pakkanen, Sari H., Pasternack, Arja, Reinholm, Arttu, Ritvos, Olli, Smura, Teemu, Tauriainen, Sisko, Tähtinen, Paula A., Vapalahti, Olli, Välimaa, Hanna, Österlund, Pamela   +26 more
core   +1 more source

Rare Adverse Events Associated with BNT162b2 mRNA Vaccine (Pfizer-BioNTech): A Review of Large-Scale, Controlled Surveillance Studies

Vaccines, 2022
Given the increasing anti-vaccine movements erroneously touting vaccine danger, this review has investigated the rare adverse events potentially associated with BNT162b2 (Pfizer-BioNTech), an mRNA vaccine against the severe acute respiratory distress ...
Shin-Jie Yong, Alice Halim, Michael Halim, Abbas Al Mutair, Saad Alhumaid, Jehad Al-Sihati, Hawra Albayat, Mohammed Alsaeed, Mohammed Garout, Reyouf Al Azmi, Noor Aldakheel, Abeer N. Alshukairi, Hani A. Al Ali, Adel A. Almoumen, Ali A. Rabaan   +14 more
doaj   +1 more source

Immune Response to SARS-CoV-2 Third Vaccine in Patients With Rheumatoid Arthritis Who Had No Seroconversion After Primary 2-Dose Regimen With Inactivated or Vector-Based Vaccines [PDF]

, 2022
Objective. The aim of this study was to assess the immune response after a third dose of SARS-CoV-2 vaccine in patients with rheumatoid arthritis (RA) with undetectable antibody titers after the primary regimen of 2 doses. Methods.
Abarza, Virginia Carrizo, Alfaro, María Agustina, Cerda, Osvaldo L., Citera, Gustavo, Crespo Rocha, María G, Cruces, Leonel Hernán, de la Vega, María Celina, de Los Ángeles Correa, Mária, Ezquer, Roberto Alejandro, Giorgis, Pamela, Gómez Vara, Andrea B., Isnardi, Carolina A., Kreplak, Nicolás, Landi, Margarita, Laufer, Natalia Lorna, Longueira, Yesica Soledad, Maid, Pablo, Montoro, Claudia Calle, Pellet, Santiago Catalan, Perandones, Miguel, Pifano, Marina, Pons Estel, Guillermo J., Quintana, Rosana Maris, Quiroga, María Florencia, Reimundes, Cecilia, Reyes Gómez, Camila R., Roldán, Brian M., Rosemffet, Marcos G., Schneeberger, Emilce E., Turk, Gabriela Julia Ana   +29 more
core   +1 more source

Comparison of anti-spike IgG, anti-spike IgA levels and neutralizing antibody activity induced by CoronaVac and BNT162b2 vaccines in patients with inflammatory rheumatic diseases receiving immunosuppressive therapy

BMC Rheumatology, 2023
Background The importance of COVID-19 vaccination for patients on immunosuppressive (IS) medication has increased due to the high risk of severe disease or mortality.
Fulya Cosan, Ozlem Unay Demirel, Demet Yalcin, Muhammed Mert Sonkaya, Isilsu Ezgi Uluisik, Olida Cecen, Yavuz Furuncuoglu, Deniz Maktav Celikmen, Osman Kara, Erkan Ceylan, Timucin Avsar   +10 more
doaj   +1 more source

Antibody and T Cell Responses against SARS-CoV-2 Elicited by the Third Dose of BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) Vaccines Using a Homologous or Heterologous Booster Vaccination Strategy

Vaccines, 2022
In the present study, antibody and T cell-mediated immune responses elicited by BBIBP-CorV and BNT162b2 vaccines were compared 6 months after the two-dose immunization of healthy individuals.
Zsolt Matula, Márton Gönczi, Gabriella Bekő, Béla Kádár, Éva Ajzner, Ferenc Uher, István Vályi-Nagy   +6 more
doaj   +1 more source